1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Sandra Esparon
Our people

Sandra Esparon

Senior Research Assistant

Working groups

sandra.esparon@burnet.edu.au
Sandra Esparon

Background

Sandra is a long-term member of the Immune Therapies group and has worked with Professor Hogarth since 1996.

She is part of the Cancer, Inflammation and Infectious Diseases projects which focus on antibody and Fc receptor therapeutic research and development. She also worked with Professor Geoff Pietersz from 1998 to 2014 focusing on antibody-drug conjugate therapeutic research and development.

Qualifications

  • 1995: BSc, Monash University, Australia

Positions

  • 2006-present: Senior Research Assistant, Burnet Institute, Australia
  • 1996-2005: Research Assistant, Austin Research Institute, Australia

Burnet publications

View 17 more
04 Oct 2024

Stellabody: A novel hexamer‐promoting mutation for improved IgG potency

Immunological Reviews

Clarissa A. Whitehead, Bruce D. Wines, Halina M. Trist, Sandra Esparon, P. Mark Hogarth

Open access
31 Mar 2023

Mutation of the TGN1412 anti‐CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super‐agonist activity

Immunology and Cell Biology

Alicia M. Chenoweth, Sandra Esparon, Bruce D. Wines, P. Mark Hogarth

Open access
10 Jan 2023

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

Frontiers in Immunology

Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Klasina Chappin, James G. Beeson, P. Mark Hogarth

Open access

Current projects

Fc receptor targeted treatments in inflammation and allergy

Fc receptor targeted treatments in inflammation and allergy

We've discovered how to selectively engage and ‘switch off’ the cells that initiate and drive inflammation, targeting specific inflammatory cells in autoimmune and allergic diseases.

Stellabody®

Stellabody®

Stellabody® is up to 100 times more effective at cell killing than standard antibody therapeutics.

Past projects

Anti-COVID-19 biological drugs for prevention and treatment

Anti-COVID-19 biological drugs for prevention and treatment

We have created a set of biological medicines that completely inhibit the COVID-19 virus.

On this page